1. Home
  2. TLSI vs EM Comparison

TLSI vs EM Comparison

Compare TLSI & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$2.70

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Logo Smart Share Global Limited

EM

Smart Share Global Limited

HOLD

Current Price

$1.20

Market Cap

296.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSI
EM
Founded
2010
2017
Country
United States
China
Employees
102
N/A
Industry
Medical Specialities
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
270.2M
296.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TLSI
EM
Price
$2.70
$1.20
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$7.00
$1.25
AVG Volume (30 Days)
407.0K
143.5K
Earning Date
05-12-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.45
$3.30
Revenue Next Year
$37.58
$5.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$1.01
52 Week High
$7.95
$1.46

Technical Indicators

Market Signals
Indicator
TLSI
EM
Relative Strength Index (RSI) 20.29 66.07
Support Level N/A $1.16
Resistance Level $5.41 $1.42
Average True Range (ATR) 0.28 0.02
MACD -0.12 0.00
Stochastic Oscillator 19.17 73.68

Price Performance

Historical Comparison
TLSI
EM

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: